SRS829763 SAMN03316853 GSM1595841 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment treated with erlotinib SRS829764 SAMN03316854 GSM1595842 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment treated with erlotinib SRS829765 SAMN03316856 GSM1595843 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment treated with erlotinib SRS829767 SAMN03316861 GSM1595845 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with PBS-1086 tissue Lung adenocarcinoma cell line 11-18 treatment treated with PBS-1086 SRS829768 SAMN03316859 GSM1595846 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with PBS-1086 tissue Lung adenocarcinoma cell line 11-18 treatment treated with PBS-1086 SRS829769 SAMN03316867 GSM1595847 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with erlotinib + PBS-1086 tissue Lung adenocarcinoma cell line 11-18 treatment treated with erlotinib + PBS-1086 SRS829771 SAMN03316870 GSM1595852 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with empty vector & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with empty vector & treated with DMSO SRS829772 SAMN03316876 GSM1595853 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with empty vector & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with empty vector & treated with erlotinib SRS829773 SAMN03316863 GSM1595854 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with empty vector & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with empty vector & treated with erlotinib SRS829775 SAMN03316866 GSM1595855 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with empty vector & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with empty vector & treated with erlotinib SRS829776 SAMN03316873 GSM1595851 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with empty vector & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with empty vector & treated with DMSO SRS829777 SAMN03316860 GSM1595856 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with vector expressing IkB-alpha super-repressor & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with vector expressing IkB-alpha super-repressor & treated with DMSO SRS829779 SAMN03316880 GSM1595857 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with vector expressing IkB-alpha super-repressor & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with vector expressing IkB-alpha super-repressor & treated with DMSO SRS829780 SAMN03316872 GSM1595858 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with vector expressing IkB-alpha super-repressor & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with vector expressing IkB-alpha super-repressor & treated with DMSO SRS829781 SAMN03316881 GSM1595859 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with vector expressing IkB-alpha super-repressor & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with vector expressing IkB-alpha super-repressor & treated with erlotinib SRS829783 SAMN03316878 GSM1595861 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with vector expressing IkB-alpha super-repressor & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with vector expressing IkB-alpha super-repressor & treated with erlotinib SRS829784 SAMN03316879 GSM1595862 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with constitutively-active RelAS536E & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with constitutively-active RelAS536E & treated with DMSO SRS829785 SAMN03316874 GSM1595863 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with constitutively-active RelAS536E & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with constitutively-active RelAS536E & treated with DMSO SRS829787 SAMN03316868 GSM1595865 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with constitutively-active RelAS536E & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with constitutively-active RelAS536E & treated with erlotinib SRS829788 SAMN03316864 GSM1595866 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with constitutively-active RelAS536E & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with constitutively-active RelAS536E & treated with erlotinib SRS829789 SAMN03316858 GSM1595867 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with constitutively-active RelAS536E & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with constitutively-active RelAS536E & treated with erlotinib SRS829761 SAMN03316855 GSM1595839 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment treated with DMSO SRS829762 SAMN03316857 GSM1595840 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment treated with DMSO SRS829766 SAMN03316877 GSM1595844 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with PBS-1086 tissue Lung adenocarcinoma cell line 11-18 treatment treated with PBS-1086 SRS829770 SAMN03316869 GSM1595850 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with empty vector & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with empty vector & treated with DMSO SRS829778 SAMN03316865 GSM1595849 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with erlotinib + PBS-1086 tissue Lung adenocarcinoma cell line 11-18 treatment treated with erlotinib + PBS-1086 SRS829782 SAMN03316871 GSM1595860 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with vector expressing IkB-alpha super-repressor & treated with erlotinib tissue Lung adenocarcinoma cell line 11-18 treatment infected with vector expressing IkB-alpha super-repressor & treated with erlotinib SRS829786 SAMN03316862 GSM1595864 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, infected with constitutively-active RelAS536E & treated with DMSO tissue Lung adenocarcinoma cell line 11-18 treatment infected with constitutively-active RelAS536E & treated with DMSO SRS829774 SAMN03316875 GSM1595848 9606 Homo sapiens bioproject 273960 PRJNA273960 source_name 11-18 cells, treated with erlotinib + PBS-1086 tissue Lung adenocarcinoma cell line 11-18 treatment treated with erlotinib + PBS-1086